Cephalon Asks FDA to Expand Uses of Pain Drug Fentora

Cephalon Inc. submitted a supplemental new drug application to the Food and Drug Administration Monday seeking approval to market its breakthrough pain cancer drug Fentora for the management of chronic pain conditions that could include lower back and neuropathic pain.
Philadelphia Business Journal